HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limiting.

AuthorsR I Fisher
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 7 Issue 7 Pg. 1835-6 (Jul 2001) ISSN: 1078-0432 [Print] United States
PMID11448891 (Publication Type: Editorial, Comment)
Chemical References
  • Antibodies, Bispecific
  • Antibodies, Monoclonal
  • Ki-1 Antigen
  • Receptors, IgG
Topics
  • Antibodies, Bispecific (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Hodgkin Disease (drug therapy, immunology)
  • Humans
  • Ki-1 Antigen (immunology)
  • Receptors, IgG (immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: